NCT04788966View on ClinicalTrials.gov

Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

January 20, 2020

Study Completion Date

January 20, 2020

Conditions
Diagnoses Disease
Interventions
DEVICE

the translation tool BabelDr

Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Trial Locations (1)

1205

University Hospitals of Geneva (HUG), Geneva

All Listed Sponsors
collaborator

University of Geneva, Switzerland

OTHER

lead

University Hospital, Geneva

OTHER

NCT04788966 - Evaluation of an Innovative Speech-enabled Translator in Emergency Settings | Biotech Hunter | Biotech Hunter